SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-005583
Filing Date
2021-03-08
Accepted
2021-03-08 16:40:59
Documents
110
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2281731
2 ex4-1.htm EX-4.1 20096
3 ex10-57.htm EX-10.57 88148
4 ex10-58.htm EX-10.58 86478
5 ex10-60.htm EX-10.60 38096
6 ex21-1.htm EX-21.1 13952
7 ex23-1.htm EX-23.1 3450
8 ex31-1.htm EX-31.1 17234
9 ex31-2.htm EX-31.2 17427
10 ex32-1.htm EX-32.1 7316
11 ex32-2.htm EX-32.2 7335
12 ex10-60_001.jpg GRAPHIC 5182
13 ex10-60_002.jpg GRAPHIC 2033
  Complete submission text file 0001493152-21-005583.txt   11131961

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE hrow-20201231.xsd EX-101.SCH 73308
15 XBRL CALCULATION FILE hrow-20201231_cal.xml EX-101.CAL 89196
16 XBRL DEFINITION FILE hrow-20201231_def.xml EX-101.DEF 351566
17 XBRL LABEL FILE hrow-20201231_lab.xml EX-101.LAB 612175
18 XBRL PRESENTATION FILE hrow-20201231_pre.xml EX-101.PRE 495629
19 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1944468
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 21722491
SIC: 2834 Pharmaceutical Preparations